Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003977 · ClinicalTrials.gov registry record · Phase 1
Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer
A Phase 1 study, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00003977: Completed Phase 1 study, sponsored by Steward St. Elizabeth's Medical Center of Boston.
NCT00003977 is a Phase 1 study that has completed, run by Steward St. Elizabeth's Medical Center of Boston. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003977, a Phase 1 study, has completed, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients with recurrent or persistent cervical cancer that cannot be treated with surgery or radiation therapy.
Interventions
- PROCEDURE in vitro-treated peripheral blood stem cell transplantation
- BIOLOGICAL human papillomavirus 16 E7 peptide
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-11 |
| Phase | Phase 1 |
What the finished NCT00003977 record still lists
NCT00003977 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which in vitro-treated peripheral blood stem cell transplantation is the first listed.
NCT00003977 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003977 about?
NCT00003977 is a clinical study titled "Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer". RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients with recurrent or persistent cervical cancer that cannot be treated with surgery or radiation therapy.
What is the current status of trial NCT00003977?
This trial is currently completed. It is a Phase 1 study. The study started on 1999-11.
What interventions are being tested in trial NCT00003977?
The interventions under investigation include: in vitro-treated peripheral blood stem cell transplantation (PROCEDURE), human papillomavirus 16 E7 peptide (BIOLOGICAL).
Who is sponsoring clinical trial NCT00003977?
This trial is sponsored by Steward St. Elizabeth's Medical Center of Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia